Akebia Therapeutics, Inc. 4
4 · Akebia Therapeutics, Inc. · Filed Feb 23, 2017
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to buy)
2017-02-21$10.14/sh+36,500$370,110→ 36,500 totalExercise: $0.00Exp: 2027-02-21→ Common Stock (36,500 underlying) - Award
Common Stock
2017-02-21+23,000→ 23,000 total
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date.
- [F2]25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.